Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

Slide Presentation from the AHRQ 2007 Annual Conference

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.


Prevalence vs. Rate of Preventable ADE's

Text Description is below the image.

Chart showing Prevalence vs. Rate of Preventable ADE's based on Prevalence and Preventable Adverse Events

Drugs included are:

  • Antibiotics (0.8, 0.1)
  • Cardiovascular (1, 1)
  • Opioids (0.4, 0.3)
  • NSAIDS (0.4, 0.6)
  • Diuretics (0.6, 0.9)
  • Antidepressants (0.2, 0.2)
  • Hypoglycemics (0.2, 0.4)
  • Anticoagulants (0.2, 0.4)
  • Antiseizure (0.1, 0.2)

Notes:

Half of the 65+ patients on Cardiovascular drugs which accounts for its high volume of ADE's.
Antibiotics also are very common, but far fewer ADE's.
In contrast, Anticoagulants are 1/7th as common, yet have a relatively high rate of ADE's.


Previous Slide Previous Slide         Contents         Next Slide Next Slide


 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care